TAVI: 60 Second Insights

Published: 28 March 2018

  • Views:

    Views Icon 5

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

A short series of 60-second insight videos on TAVI.

More from this programme

Part 1

Do you think it is necessary to perform coronary revascularisation pre-TAVR? Do you use FFR/iFR decision-making?

2 sessions
Nicolas Van Mieghem Watch now
Francesco Maisano Watch now

Part 2

Are we ready to be doing TAVR in low risk patients?

2 sessions
Nicolas Van Mieghem Watch now
Francesco Maisano Watch now

Part 3

Which patients are you performing TAVR in now (High/Medium risk)?

2 sessions
Nicolas Van Mieghem Watch now
Francesco Maisano Watch now

Part 4

Which is your preferred valve, and why?

2 sessions
Nicolas Van Mieghem Watch now
Francesco Maisano Watch now

Part 5

How would you recommend someone start a TAVR program?

2 sessions
Nicolas Van Mieghem Watch now
Francesco Maisano Watch now

Part 6

What is the most important clinical trial data and why?

2 sessions
Nicolas Van Mieghem Watch now
Francesco Maisano Watch now

Part 7

What is the biggest innovation in TAVR over the past 12-24 months?

2 sessions
Nicolas Van Mieghem Watch now
Francesco Maisano Watch now

Part 8

What proportion of your patients have a TAVR rather than and surgical AVR?

2 sessions
Nicolas Van Mieghem Watch now
Francesco Maisano Watch now

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Medical Director

Dr Nicolas M Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology at the Thoraxcenter, Erasmus Medical Center, as a senior staff member in February 2010. 

He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored approximately 130 scientific papers in peer-reviewed journals. 

Dr Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and is currently…

View full profile